Capmatinib and savotinib prices

Capmatinib and cervotinib are antineoplastic drugs indicated for adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have mutations that cause mesenchymal epithelial transition (MET) exon 14skipping.

Capmatinib (Capmatinib) is produced by Novartis, and Savotinib is produced by Shanghai Hequan Pharmaceutical Co., Ltd.. The retail price of saivotinib in pharmacies is about 200mg*21 tablets4700 yuan. CapmatinibThere are original drugs and generic drugs overseas. The original drug is available in Hong Kong. The retail price of the Hong Kong version in pharmacies is about 200mg60pills35,000 yuan. The retail price of the European version in pharmacies is about 200mg120pills57,000yuan. There are generic drugs in Laos. The retail price of Lucius Pharmaceuticals in Laos is more than 200mg60capsules3 more than 1,000. The retail price of Daxiong Pharmaceutical in Laos is more than 1,000 for 200 mg 56 tablets. The retail price of Laos United Pharmaceuticals200mg56capsules3 is more than one thousand. The retail price of Laos Element Pharmaceuticals is about 200mg 56 tablets 4 about one thousand.

The effects of capmatinib were studied in a major study involving 100 patients with "METex14 skipping" mutated advanced non-small cell lung cancer whose disease had progressed after prior immunotherapy with platinum-containing or platinum-free chemotherapy. Using body scans to assess response to treatment (reduction in cancer size), 44% of patients who received capmatinib showed partial or complete reduction in cancer size. On average, this reaction lasted at least10 months. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.